name: Removal of Packing Material on Left Upper Extremity


name: Removal of Pressure Dressing on Left Upper Extremity


name: Removal of Intermittent Pressure Device on Left Upper Extremity


name: Removal of Other Device on Left Upper Extremity


name: Removal of Traction Apparatus on Right Upper Arm


name: Removal of Packing Material on Right Upper Arm


name: Removal of Pressure Dressing on Right Upper Arm


name: Removal of Intermittent Pressure Device on Right Upper Arm


name: Removal of Other Device on Right Upper Arm


name: Removal of Traction Apparatus on Left Upper Arm


name: Removal of Packing Material on Left Upper Arm


name: Removal of Pressure Dressing on Left Upper Arm


name: Removal of Intermittent Pressure Device on Left Upper Arm


name: Removal of Other Device on Left Upper Arm


name: Removal of Traction Apparatus on Right Lower Arm


name: Removal of Packing Material on Right Lower Arm


name: Removal of Pressure Dressing on Right Lower Arm


name: Removal of Intermittent Pressure Device on Right Lower Arm


name: Removal of Other Device on Right Lower Arm


name: Removal of Traction Apparatus on Left Lower Arm


name: Removal of Packing Material on Left Lower Arm


name: Removal of Pressure Dressing on Left Lower Arm


name: Removal of Intermittent Pressure Device on Left Lower Arm


name: Removal of Other Device on Left Lower Arm


name: Removal of Traction Apparatus on Right Hand


name: Removal of Packing Material on Right Hand


name: Removal of Pressure Dressing on Right Hand


name: Removal of Intermittent Pressure Device on Right Hand


name: Removal of Traction Apparatus on Left Hand


name: Removal of Packing Material on Left Hand


name: Removal of Pressure Dressing on Left Hand


name: Removal of Intermittent Pressure Device on Left Hand


name: Removal of Traction Apparatus on Right Thumb


name: Removal of Packing Material on Right Thumb


name: Removal of Pressure Dressing on Right Thumb


name: Removal of Intermittent Pressure Device on Right Thumb


name: Removal of Traction Apparatus on Left Thumb


name: Removal of Packing Material on Left Thumb


name: Removal of Pressure Dressing on Left Thumb


name: Removal of Intermittent Pressure Device on Left Thumb


name: Removal of Traction Apparatus on Right Finger


name: Removal of Packing Material on Right Finger


name: Removal of Pressure Dressing on Right Finger


name: Removal of Intermittent Pressure Device on Right Finger


name: Removal of Traction Apparatus on Left Finger


name: Removal of Packing Material on Left Finger


name: Removal of Pressure Dressing on Left Finger


name: Removal of Intermittent Pressure Device on Left Finger


name: Removal of Traction Apparatus on Right Lower Extremity


name: Removal of Splint on Right Lower Extremity


name: Removal of Cast on Right Lower Extremity


name: Removal of Brace on Right Lower Extremity


name: Removal of Bandage on Right Lower Extremity


name: Removal of Packing Material on Right Lower Extremity


name: Removal of Pressure Dressing on Right Lower Extremity


name: Removal of Intermittent Pressure Device on Right Lower Extremity


name: Removal of Other Device on Right Lower Extremity


name: Removal of Traction Apparatus on Left Lower Extremity


name: Removal of Splint on Left Lower Extremity


name: Removal of Brace on Left Lower Extremity


name: Removal of Bandage on Left Lower Extremity


name: Removal of Packing Material on Left Lower Extremity


name: Removal of Pressure Dressing on Left Lower Extremity


name: Removal of Intermittent Pressure Device on Left Lower Extremity


name: Removal of Other Device on Left Lower Extremity


name: Removal of Traction Apparatus on Right Upper Leg


name: Removal of Packing Material on Right Upper Leg


name: Removal of Pressure Dressing on Right Upper Leg


name: Removal of Intermittent Pressure Device on Right Upper Leg


name: Removal of Other Device on Right Upper Leg


name: Removal of Traction Apparatus on Left Upper Leg


name: Removal of Packing Material on Left Upper Leg


name: Removal of Pressure Dressing on Left Upper Leg


name: Removal of Intermittent Pressure Device on Left Upper Leg


name: Removal of Other Device on Left Upper Leg


name: Removal of Traction Apparatus on Right Lower Leg


name: Removal of Packing Material on Right Lower Leg


name: Removal of Pressure Dressing on Right Lower Leg


name: Removal of Intermittent Pressure Device on Right Lower Leg


name: Removal of Other Device on Right Lower Leg


name: Removal of Traction Apparatus on Left Lower Leg


name: Removal of Packing Material on Left Lower Leg


name: Removal of Pressure Dressing on Left Lower Leg


name: Removal of Intermittent Pressure Device on Left Lower Leg


name: Removal of Other Device on Left Lower Leg


name: Removal of Traction Apparatus on Right Foot


name: Removal of Packing Material on Right Foot


name: Removal of Pressure Dressing on Right Foot


name: Removal of Intermittent Pressure Device on Right Foot


name: Removal of Traction Apparatus on Left Foot


name: Removal of Packing Material on Left Foot


name: Removal of Pressure Dressing on Left Foot


name: Removal of Intermittent Pressure Device on Left Foot


name: Removal of Traction Apparatus on Right Toe


name: Removal of Packing Material on Right Toe


name: Removal of Pressure Dressing on Right Toe


name: Removal of Intermittent Pressure Device on Right Toe


name: Removal of Traction Apparatus on Left Toe


name: Removal of Pressure Dressing on Left Toe


name: Removal of Intermittent Pressure Device on Left Toe


name: Traction of Head using Traction Apparatus


name: Traction of Face using Traction Apparatus


name: Traction of Neck using Traction Apparatus


name: Traction of Abdominal Wall using Traction Apparatus


name: Traction of Chest Wall using Traction Apparatus


name: Traction of Back using Traction Apparatus


name: Traction of Right Inguinal Region using Traction Apparatus


name: Traction of Left Inguinal Region using Traction Apparatus


name: Traction of Right Upper Extremity using Traction Apparatus


name: Traction of Left Upper Extremity using Traction Apparatus


name: Traction of Right Upper Arm using Traction Apparatus


name: Traction of Left Upper Arm using Traction Apparatus


name: Traction of Right Lower Arm using Traction Apparatus


name: Traction of Left Lower Arm using Traction Apparatus


name: Traction of Right Hand using Traction Apparatus


name: Traction of Left Hand using Traction Apparatus


name: Traction of Right Thumb using Traction Apparatus


name: Traction of Left Thumb using Traction Apparatus


name: Traction of Right Finger using Traction Apparatus


name: Traction of Left Finger using Traction Apparatus


name: Traction of Right Lower Extremity using Traction Apparatus


name: Traction of Left Lower Extremity using Traction Apparatus


name: Traction of Right Upper Leg using Traction Apparatus


name: Traction of Left Upper Leg using Traction Apparatus


name: Traction of Right Lower Leg using Traction Apparatus


name: Traction of Left Lower Leg using Traction Apparatus


name: Traction of Right Foot using Traction Apparatus


name: Traction of Left Foot using Traction Apparatus


name: Traction of Right Toe using Traction Apparatus


name: Traction of Left Toe using Traction Apparatus


name: Change Mouth and Pharynx Packing Material


name: Change Female Genital Tract Packing Material


name: Packing of Mouth and Pharynx using Packing Material


name: Packing of Nasal Region using Packing Material


name: Packing of Anorectal Region using Packing Material


name: Packing of Female Genital Tract using Packing Material


name: Packing of Urethra using Packing Material


name: Removal of Mouth and Pharynx Packing Material


name: Removal of Female Genital Tract Packing Material


name: Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Whole Blood into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Serum Albumin into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Serum Albumin into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Frozen Plasma into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Plasma into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Fresh Plasma into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Fresh Plasma into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Plasma Cryoprecipitate into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Plasma Cryoprecipitate into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Red Blood Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Frozen Red Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Red Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous White Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous White Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Platelets into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Globulin into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Globulin into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Fibrinogen into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Fibrinogen into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Antihemophilic Factors into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Antihemophilic Factors into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Factor IX into Peripheral Vein, Percutaneous Approach


name: Transfusion of Nonautologous Factor IX into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Whole Blood into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Serum Albumin into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Serum Albumin into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Frozen Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Fresh Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Fresh Plasma into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Plasma Cryoprecipitate into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Plasma Cryoprecipitate into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Red Blood Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Red Blood Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Frozen Red Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Red Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous White Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous White Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Platelets into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Platelets into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Globulin into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Globulin into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Fibrinogen into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Fibrinogen into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Antihemophilic Factors into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Antihemophilic Factors into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Factor IX into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Factor IX into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Percutaneous Approach


name: Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Via Natural or Artificial Opening


name: Irrigation of Indwelling Device using Irrigating Substance, External Approach


name: Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach


name: Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach


name: Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach


name: Introduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach


name: Introduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach


name: Introduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach


name: Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach


name: Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach


name: Introduction of Pigment into Skin and Mucous Membranes, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach


name: Introduction of Destructive Agent into Skin and Mucous Membranes, External Approach


name: Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach


name: Introduction of Other Antineoplastic into Muscle, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach


name: Introduction of Oxazolidinones into Muscle, Percutaneous Approach


name: Introduction of Other Anti-infective into Muscle, Percutaneous Approach


name: Introduction of Anti-inflammatory into Muscle, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach


name: Introduction of Nutritional Substance into Muscle, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Muscle, Percutaneous Approach


name: Introduction of Anesthetic Agent into Muscle, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Muscle, Percutaneous Approach


name: Introduction of Radioactive Substance into Muscle, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Muscle, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Muscle, Percutaneous Approach


name: Introduction of Destructive Agent into Muscle, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach


name: Introduction of Other Antineoplastic into Peripheral Vein, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open


name: Introduction of Other Thrombolytic into Peripheral Vein, Open Approach


name: Introduction of Oxazolidinones into Peripheral Vein, Open Approach


name: Introduction of Other Anti-infective into Peripheral Vein, Open Approach


name: Introduction of Anti-inflammatory into Peripheral Vein, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach


name: Introduction of Nutritional Substance into Peripheral Vein, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach


name: Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach


name: Introduction of Radioactive Substance into Peripheral Vein, Open Approach


name: Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach


name: Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach


name: Introduction of Antiarrhythmic into Peripheral Vein, Open Approach


name: Introduction of Destructive Agent into Peripheral Vein, Open Approach


name: Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach


name: Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach


name: Introduction of Insulin into Peripheral Vein, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach


name: Introduction of Other Hormone into Peripheral Vein, Open Approach


name: Introduction of Immunostimulator into Peripheral Vein, Open


name: Introduction of Immunosuppressive into Peripheral Vein, Open


name: Introduction of Vasopressor into Peripheral Vein, Open Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous


name: Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach


name: Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach


name: Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach


name: Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach


name: Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach


name: Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach


name: Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach


name: Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach


name: Introduction of Insulin into Peripheral Vein, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach


name: Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach


name: Introduction of Immunostimulator into Peripheral Vein, Percutaneous


name: Introduction of Immunosuppressive into Peripheral Vein, Percutaneous


name: Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Central Vein, Open Approach


name: Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach


name: Introduction of Other Antineoplastic into Central Vein, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Central Vein, Open


name: Introduction of Other Thrombolytic into Central Vein, Open Approach


name: Introduction of Oxazolidinones into Central Vein, Open Approach


name: Introduction of Other Anti-infective into Central Vein, Open Approach


name: Introduction of Anti-inflammatory into Central Vein, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach


name: Introduction of Nutritional Substance into Central Vein, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach


name: Introduction of Intracirculatory Anesthetic into Central Vein, Open Approach


name: Introduction of Other Therapeutic Substance into Central Vein, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach


name: Introduction of Radioactive Substance into Central Vein, Open Approach


name: Introduction of Other Diagnostic Substance into Central Vein, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach


name: Introduction of Platelet Inhibitor into Central Vein, Open Approach


name: Introduction of Antiarrhythmic into Central Vein, Open Approach


name: Introduction of Destructive Agent into Central Vein, Open Approach


name: Introduction of Insulin into Central Vein, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach


name: Introduction of Other Hormone into Central Vein, Open Approach


name: Introduction of Immunostimulator into Central Vein, Open


name: Introduction of Immunosuppressive into Central Vein, Open


name: Introduction of Vasopressor into Central Vein, Open Approach


name: Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach


name: Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous


name: Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach


name: Introduction of Oxazolidinones into Central Vein, Percutaneous Approach


name: Introduction of Other Anti-infective into Central Vein, Percutaneous Approach


name: Introduction of Anti-inflammatory into Central Vein, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach


name: Introduction of Nutritional Substance into Central Vein, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach


name: Introduction of Radioactive Substance into Central Vein, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Central Vein, Percutaneous Approach


name: Introduction of Antiarrhythmic into Central Vein, Percutaneous Approach


name: Introduction of Destructive Agent into Central Vein, Percutaneous Approach


name: Introduction of Insulin into Central Vein, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach


name: Introduction of Other Hormone into Central Vein, Percutaneous Approach


name: Introduction of Immunostimulator into Central Vein, Percutaneous


name: Introduction of Immunosuppressive into Central Vein, Percutaneous


name: Introduction of Vasopressor into Central Vein, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach


name: Introduction of Other Antineoplastic into Peripheral Artery, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open


name: Introduction of Other Thrombolytic into Peripheral Artery, Open Approach


name: Introduction of Oxazolidinones into Peripheral Artery, Open Approach


name: Introduction of Other Anti-infective into Peripheral Artery, Open Approach


name: Introduction of Anti-inflammatory into Peripheral Artery, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach


name: Introduction of Nutritional Substance into Peripheral Artery, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach


name: Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach


name: Introduction of Radioactive Substance into Peripheral Artery, Open Approach


name: Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach


name: Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach


name: Introduction of Antiarrhythmic into Peripheral Artery, Open Approach


name: Introduction of Destructive Agent into Peripheral Artery, Open Approach


name: Introduction of Insulin into Peripheral Artery, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach


name: Introduction of Other Hormone into Peripheral Artery, Open Approach


name: Introduction of Immunostimulator into Peripheral Artery, Open


name: Introduction of Immunosuppressive into Peripheral Artery, Open


name: Introduction of Vasopressor into Peripheral Artery, Open Approach


name: Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous


name: Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach


name: Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach


name: Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach


name: Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach


name: Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach


name: Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach


name: Introduction of Insulin into Peripheral Artery, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach


name: Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach


name: Introduction of Immunostimulator into Peripheral Artery, Percutaneous


name: Introduction of Immunosuppressive into Peripheral Artery, Percutaneous


name: Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach


name: Introduction of High-dose Interleukin-2 into Central Artery, Open Approach


name: Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach


name: Introduction of Other Antineoplastic into Central Artery, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Central Artery, Open


name: Introduction of Other Thrombolytic into Central Artery, Open Approach


name: Introduction of Oxazolidinones into Central Artery, Open Approach


name: Introduction of Other Anti-infective into Central Artery, Open Approach


name: Introduction of Anti-inflammatory into Central Artery, Open Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Artery, Open Approach


name: Introduction of Nutritional Substance into Central Artery, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Artery, Open Approach


name: Introduction of Intracirculatory Anesthetic into Central Artery, Open Approach


name: Introduction of Other Therapeutic Substance into Central Artery, Open Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Open Approach


name: Introduction of Radioactive Substance into Central Artery, Open Approach


name: Introduction of Other Diagnostic Substance into Central Artery, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Open Approach


name: Introduction of Platelet Inhibitor into Central Artery, Open Approach


name: Introduction of Antiarrhythmic into Central Artery, Open Approach


name: Introduction of Destructive Agent into Central Artery, Open Approach


name: Introduction of Insulin into Central Artery, Open Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Artery, Open Approach


name: Introduction of Other Hormone into Central Artery, Open Approach


name: Introduction of Immunostimulator into Central Artery, Open


name: Introduction of Immunosuppressive into Central Artery, Open


name: Introduction of Vasopressor into Central Artery, Open Approach


name: Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach


name: Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach


name: Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous


name: Introduction of Other Thrombolytic into Central Artery, Percutaneous Approach


name: Introduction of Oxazolidinones into Central Artery, Percutaneous Approach


name: Introduction of Other Anti-infective into Central Artery, Percutaneous Approach


name: Introduction of Anti-inflammatory into Central Artery, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Central Artery, Percutaneous Approach


name: Introduction of Nutritional Substance into Central Artery, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Central Artery, Percutaneous Approach


name: Introduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Central Artery, Percutaneous Approach


name: Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Percutaneous Approach


name: Introduction of Radioactive Substance into Central Artery, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Central Artery, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Central Artery, Percutaneous Approach


name: Introduction of Antiarrhythmic into Central Artery, Percutaneous Approach


name: Introduction of Destructive Agent into Central Artery, Percutaneous Approach


name: Introduction of Insulin into Central Artery, Percutaneous Approach


name: Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach


name: Introduction of Other Hormone into Central Artery, Percutaneous Approach


name: Introduction of Immunostimulator into Central Artery, Percutaneous


name: Introduction of Immunosuppressive into Central Artery, Percutaneous


name: Introduction of Vasopressor into Central Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Coronary Artery, Open


name: Introduction of Other Thrombolytic into Coronary Artery, Open Approach


name: Introduction of Other Therapeutic Substance into Coronary Artery, Open Approach


name: Introduction of Other Diagnostic Substance into Coronary Artery, Open Approach


name: Introduction of Platelet Inhibitor into Coronary Artery, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous


name: Introduction of Other Thrombolytic into Coronary Artery, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Coronary Artery, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Coronary Artery, Percutaneous Approach


name: Introduction of Recombinant Human-activated Protein C into Heart, Open


name: Introduction of Other Thrombolytic into Heart, Open Approach


name: Introduction of Other Therapeutic Substance into Heart, Open Approach


name: Introduction of Other Diagnostic Substance into Heart, Open Approach


name: Introduction of Platelet Inhibitor into Heart, Open Approach


name: Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous


name: Introduction of Other Thrombolytic into Heart, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Heart, Percutaneous Approach


name: Introduction of Platelet Inhibitor into Heart, Percutaneous Approach


name: Introduction of Other Antineoplastic into Nose, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach


name: Introduction of Oxazolidinones into Nose, Percutaneous Approach


name: Introduction of Other Anti-infective into Nose, Percutaneous Approach


name: Introduction of Anti-inflammatory into Nose, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach


name: Introduction of Anesthetic Agent into Nose, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Nose, Percutaneous Approach


name: Introduction of Radioactive Substance into Nose, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Nose, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach


name: Introduction of Destructive Agent into Nose, Percutaneous Approach


name: Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Nose, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Nose, Via Natural or Artificial Opening


name: Introduction of Serum, Toxoid and Vaccine into Nose, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Nose, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Nose, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Nose, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Nose, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Nose, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Nose, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Nose, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach


name: Introduction of Oxazolidinones into Nose, External Approach


name: Introduction of Other Anti-infective into Nose, External Approach


name: Introduction of Anti-inflammatory into Nose, External Approach


name: Introduction of Serum, Toxoid and Vaccine into Nose, External Approach


name: Introduction of Anesthetic Agent into Nose, External Approach


name: Introduction of Other Therapeutic Substance into Nose, External Approach


name: Introduction of Radioactive Substance into Nose, External Approach


name: Introduction of Other Diagnostic Substance into Nose, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Nose, External Approach


name: Introduction of Destructive Agent into Nose, External Approach


name: Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Bone Marrow, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Ear, Percutaneous Approach


name: Introduction of Other Antineoplastic into Ear, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach


name: Introduction of Oxazolidinones into Ear, Percutaneous Approach


name: Introduction of Other Anti-infective into Ear, Percutaneous Approach


name: Introduction of Anti-inflammatory into Ear, Percutaneous Approach


name: Introduction of Anesthetic Agent into Ear, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Ear, Percutaneous Approach


name: Introduction of Radioactive Substance into Ear, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Ear, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Ear, Percutaneous Approach


name: Introduction of Destructive Agent into Ear, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Ear, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Ear, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Ear, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Ear, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Ear, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Ear, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Ear, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Ear, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Ear, External Approach


name: Introduction of Other Antineoplastic into Ear, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach


name: Introduction of Oxazolidinones into Ear, External Approach


name: Introduction of Other Anti-infective into Ear, External Approach


name: Introduction of Anti-inflammatory into Ear, External Approach


name: Introduction of Anesthetic Agent into Ear, External Approach


name: Introduction of Other Therapeutic Substance into Ear, External Approach


name: Introduction of Radioactive Substance into Ear, External Approach


name: Introduction of Other Diagnostic Substance into Ear, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Ear, External Approach


name: Introduction of Destructive Agent into Ear, External Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach


name: Introduction of Other Antineoplastic into Eye, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach


name: Introduction of Oxazolidinones into Eye, Percutaneous Approach


name: Introduction of Other Anti-infective into Eye, Percutaneous Approach


name: Introduction of Anti-inflammatory into Eye, Percutaneous Approach


name: Introduction of Anesthetic Agent into Eye, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach


name: Introduction of Radioactive Substance into Eye, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Eye, Percutaneous Approach


name: Introduction of Pigment into Eye, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Eye, Percutaneous Approach


name: Introduction of Other Gas into Eye, Percutaneous Approach


name: Introduction of Destructive Agent into Eye, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Eye, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Eye, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Eye, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Eye, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Eye, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Eye, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Eye, Via Natural or Artificial Opening


name: Introduction of Pigment into Eye, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Eye, Via Natural or Artificial Opening


name: Introduction of Other Gas into Eye, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Eye, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Eye, External Approach


name: Introduction of Other Antineoplastic into Eye, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach


name: Introduction of Oxazolidinones into Eye, External Approach


name: Introduction of Other Anti-infective into Eye, External Approach


name: Introduction of Anti-inflammatory into Eye, External Approach


name: Introduction of Anesthetic Agent into Eye, External Approach


name: Introduction of Other Therapeutic Substance into Eye, External Approach


name: Introduction of Radioactive Substance into Eye, External Approach


name: Introduction of Other Diagnostic Substance into Eye, External Approach


name: Introduction of Pigment into Eye, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Eye, External Approach


name: Introduction of Other Gas into Eye, External Approach


name: Introduction of Destructive Agent into Eye, External Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Anti-infective into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Anti-inflammatory into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Nutritional Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Anesthetic Agent into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Radioactive Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Antiarrhythmic into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Antiarrhythmic into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, External Approach


name: Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach


name: Introduction of Oxazolidinones into Mouth and Pharynx, External Approach


name: Introduction of Other Anti-infective into Mouth and Pharynx, External Approach


name: Introduction of Anti-inflammatory into Mouth and Pharynx, External Approach


name: Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, External Approach


name: Introduction of Nutritional Substance into Mouth and Pharynx, External Approach


name: Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, External Approach


name: Introduction of Anesthetic Agent into Mouth and Pharynx, External Approach


name: Introduction of Other Therapeutic Substance into Mouth and Pharynx, External Approach


name: Introduction of Radioactive Substance into Mouth and Pharynx, External Approach


name: Introduction of Other Diagnostic Substance into Mouth and Pharynx, External Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, External Approach


name: Introduction of Antiarrhythmic into Mouth and Pharynx, External Approach


name: Introduction of Destructive Agent into Mouth and Pharynx, External Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach


name: Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach


name: Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach


name: Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach


name: Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach


name: Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach


name: Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach


name: Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach


name: Introduction of Other Gas into Products of Conception, Percutaneous Approach


name: Introduction of Destructive Agent into Products of Conception, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach


name: Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach


name: Introduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach


name: Introduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach


name: Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach


name: Introduction of Other Gas into Respiratory Tract, Percutaneous Approach


name: Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Percutaneous Approach


name: Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach


name: Introduction of Oxazolidinones into Upper GI, Percutaneous Approach


name: Introduction of Other Anti-infective into Upper GI, Percutaneous Approach


name: Introduction of Anti-inflammatory into Upper GI, Percutaneous Approach


name: Introduction of Nutritional Substance into Upper GI, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Upper GI, Percutaneous Approach


name: Introduction of Anesthetic Agent into Upper GI, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach


name: Introduction of Radioactive Substance into Upper GI, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Upper GI, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Percutaneous Approach


name: Introduction of Other Gas into Upper GI, Percutaneous Approach


name: Introduction of Destructive Agent into Upper GI, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening


name: Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Percutaneous Approach


name: Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach


name: Introduction of Oxazolidinones into Lower GI, Percutaneous Approach


name: Introduction of Other Anti-infective into Lower GI, Percutaneous Approach


name: Introduction of Anti-inflammatory into Lower GI, Percutaneous Approach


name: Introduction of Nutritional Substance into Lower GI, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Lower GI, Percutaneous Approach


name: Introduction of Anesthetic Agent into Lower GI, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Lower GI, Percutaneous Approach


name: Introduction of Radioactive Substance into Lower GI, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Lower GI, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Percutaneous Approach


name: Introduction of Other Gas into Lower GI, Percutaneous Approach


name: Introduction of Destructive Agent into Lower GI, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening


name: Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach


name: Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Anti-infective into Genitourinary Tract, Percutaneous Approach


name: Introduction of Anti-inflammatory into Genitourinary Tract, Percutaneous Approach


name: Introduction of Nutritional Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Anesthetic Agent into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Radioactive Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Genitourinary Tract, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Percutaneous Approach


name: Introduction of Other Gas into Genitourinary Tract, Percutaneous Approach


name: Introduction of Destructive Agent into Genitourinary Tract, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic


name: Introduction of Adhesion Barrier into Pleural Cavity, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach


name: Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach


name: Introduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach


name: Introduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Radioactive Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach


name: Introduction of Other Gas into Pleural Cavity, Percutaneous Approach


name: Introduction of Destructive Agent into Pleural Cavity, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening


name: Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Percutaneous Approach


name: Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach


name: Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach


name: Introduction of Other Anti-infective into Male Reproductive, Percutaneous Approach


name: Introduction of Anti-inflammatory into Male Reproductive, Percutaneous Approach


name: Introduction of Nutritional Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Anesthetic Agent into Male Reproductive, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Radioactive Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Male Reproductive, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Percutaneous Approach


name: Introduction of Other Gas into Male Reproductive, Percutaneous Approach


name: Introduction of Destructive Agent into Male Reproductive, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Adhesion Barrier into Female Reproductive, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach


name: Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach


name: Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach


name: Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach


name: Introduction of Anti-inflammatory into Female Reproductive, Percutaneous Approach


name: Introduction of Nutritional Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Anesthetic Agent into Female Reproductive, Percutaneous Approach


name: Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Radioactive Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Other Diagnostic Substance into Female Reproductive, Percutaneous Approach


name: Introduction of Sperm into Female Reproductive, Percutaneous Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Percutaneous Approach


name: Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach


name: Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach


name: Introduction of Other Gas into Female Reproductive, Percutaneous Approach


name: Introduction of Destructive Agent into Female Reproductive, Percutaneous Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Sperm into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Autologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening


name: Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic


name: Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach


name: Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach


name: Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach


name: Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach